Protein Tyrosine Kinase Inhibitors Act Downstream of IL-1α and LPS Stimulated MAP-Kinase Phosphorylation to Inhibit Expression of E-Selectin on Human Umbilical Vein Endothelial Cells

References

• Adamson P., Tighe M., Paterson H. F., Pearson J. D. Induction of E-selectin by endotoxin is direct and not mediated through intracellular or extracellular release of secondary cytokines. Endothelium 1994, in press
   Google Scholar
• Akiyama T., Ishida J., Nakagawa S., Ogawara H., Wantanabe S., Itoh N., Shibuya M., Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 1987; 262: 5592–5595
   PubMed Web of Science ®Google Scholar
• Asahi M., Yanagi S., Ohta A., Inazu T., Sakai K., Takeuchi F., Taniguchi T., Yamamura H. Thrombin induced human platelet aggregation is inhibited by protein-tyrosine kinase inhibitors, ST638 and genistein. FEBS Lett. 1992; 309: 10–14
   PubMed Web of Science ®Google Scholar
• Bazil V., Horejsi V., Baudys M., Kristofova H., Strominger J., Kostka W., Hilgert I. Biochemical characterisation of a soluble form of the 53 Kda monocyte surface antigen. Eur. J. Immunol. 1986; 16: 1583–1589
   PubMed Web of Science ®Google Scholar
• Bevilaqua M. P., Pober J. S., Mendrick D. L., Cotran R. S., Gimbrone M. A., Jr. Identification of an inducible endo-thelial-leukocyte adhesion molecule. Proc. Natl. Acad. Sci. USA 1987; 84: 9238–9242
   PubMed Web of Science ®Google Scholar
• Bevilaqua M. P. Endothelial-Leukocyte adhesion molecules. Ann. Rev. Immunol. 1993; 11: 767–804
   PubMed Web of Science ®Google Scholar
• Carlos T. M., Schwartz B. R., Kovach N. L., Yee E., Rosso M., Osborn L., Chi-Rosso G., Newman B., Lobb R., Harlan J. Vascular cell adhesion molecule 1 mediates lymphocyte adherence to cytokine activated cultured human endothelial cells. Blood 1990; 76: 965–970
   PubMed Web of Science ®Google Scholar
• Chomczynski P., Sacchi N. Single step method of RNA isolation by guanidine thiocyanate-phenol-chloroform extraction. Anal. Biochem. 1987; 162: 156–159
   PubMed Web of Science ®Google Scholar
• Colucci M., Balconi G., Lorenzet R., Pietra A., Locati D., Donati M. B., Semeraro N. Cultured human endothelial cells generate tissue factor in response to endotoxin. J. Clin. Invest. 1983; 71: 1863–1896
   Web of Science ®Google Scholar
• Coyne D. W., Morrison A. R. Effect of the tyrosine kinase inhibitor genistein on interleukin 1 stimulated PGI2 production in mesangial cells. Biochem. Biophys. Res. Commun. 1990; 173: 718–724
   PubMed Web of Science ®Google Scholar
• Grossman D. C., Carr D. P., Tuddenham E. G. D., Pearson J. D., McVey J. H. The control of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester. J. Biol. Chem. 1990; 265: 9782–9787
   PubMed Web of Science ®Google Scholar
• Dong Z., O'Brien C. A., Fidler I. J. Activation of tumouricidal properties of macrophages by lipopolysaccharide requires protein tyrosine kinase activity. J. Leukocyte Biol. 1993a; 53: 53–60
   PubMed Web of Science ®Google Scholar
• Dong Z., Qi X., Xie K., Fidler I. J. Protein tyrosine kinase inhibitors decrease induction of nitric oxide synthase activity in lipopolysaccharide-responsive and lipopolysaccharide non-responsive murine macrophages. J Immunol. 1993b; 151: 2717–2724
   PubMed Web of Science ®Google Scholar
• Dustin M. L., Springer T. A. Lymphocyte function associated antigen-1 (LFA-1) interaction with intracellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells. J. Cell. Biol. 1988; 107: 321–331
   PubMed Web of Science ®Google Scholar
• English B. K., Ihle J. N., Myracle A., Yi T. Hck tyrosine kinase activity modulates tumour necrosis factor production by murine macrophages. J. Exp. Med. 1993; 178: 1017–1022
   PubMed Web of Science ®Google Scholar
• Evan J. P., Mire-Sluis A. R., Hoffbrand A. V., Wickremasinghe R. G. Binding of G-CSF, GM-CSF, Tumour necrosis factor- and -interferon to cell surface receptors trigger rapid tyrosine and serine phosphorylation of a 75Kd protein. Blood 1988; 75: 88–90
   Web of Science ®Google Scholar
• Everaerdt B., Broukaert P., Shaw A., Fiers W. Four different interleukin-1 species sensitise to the lethal action of tumour necrosis factor. Biochem. Biophys. Res. Commun. 1989; 163: 378–385
   PubMed Web of Science ®Google Scholar
• Frey E. A., Miller D. S., Jahr T. G., Sundan A., Bazil V., Espevik T., Finlay B. B., Wright S. D. Soluble CD14 participates in the response of cells to lipopolysaccharide. J. Exp. Med. 1992; 176: 16665–16671
   Web of Science ®Google Scholar
• Glaser K. B., Sung A., Bauer J., Weichman B. M. Regulation of eicosanoid biosynthesis in the macrophage: involvement of protein tyrosine phosphorylation and modulation by selective protein tyrosine kinase inhibitors. Biochem. Pharmacol. 1993; 45: 711–721
   PubMed Web of Science ®Google Scholar
• Glauser M. P., Zanetti G., Baumgartner D., Cohen J. Septic shock pathogenesis. Lancet. 1991; 338: 732–736
   PubMed Web of Science ®Google Scholar
• Guy G. R., Chua S. P., Wong S. N., Ng N. B., Tan Y. H. Interleukin 1 and tumour necrosis factor activate common multiple protein kinases in human fibroblasts. J. Biol. Chem. 1991; 266: 14343–14352
   PubMed Web of Science ®Google Scholar
• Hoffman W. D., Pollack M., Banks S. M., Koev L. A., Solomon M. A., Danner R. L., Koles N., Guelde G., Yatsiv I., Mouginis T., Elin R. J., Hosseini J. M., Bacher J., Porter J. C., Natanson C. Distinct functional activities in canine septic shock of monoclonal antibodies specific for the O-polysaccharide and core regions of Escherichia coli lipopolysaccharide. J. Infec. Dis. 1994; 169: 553–561
   PubMed Web of Science ®Google Scholar
• Iwasaki T., Uehara Y., Graves L., Rachie N., Bomsztyk K. Herbimycin A blocks IL-1α induced NFkB binding activity in lymphoid cells. FEBS Lett. 1992; 298: 240–244
   PubMed Web of Science ®Google Scholar
• Jaffe E. A., Nachman R. L., Becker C. G., Minick C. R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J. Clin. Invest. 1973; 52: 2745–2756
   PubMed Web of Science ®Google Scholar
• Khomo M., Nishizawa N., Tsujimoto M., Nomoto H. Mitogenic signalling pathway of tumour necrosis factor involves the rapid tyrosine phosphorylation of 41,000-Mr and 43,000-Mr cytosol proteins. Biochem. J. 1990; 267: 91–98
   PubMed Web of Science ®Google Scholar
• Kiener P. A., Marek F., Rodgers G., Lin P F., Warr G., Disiderio J. Induction of tumour necrosis factor, IFN-and acute lethality in mice by toxic and non toxic forms of lipid A. J. Immunol. 1988; 57: 870–874
   Google Scholar
• Kilbourn R. G., Gross S. S., Jubran A., Adams J., Griffith O. W., Levi R., Lodato R. F. NG-methyl-L-arginine inhibits tumour necrosis factor induced hypotension: Implication for the role of nitric oxide. Proc. Natl Acad. Sci. USA 1990; 87: 3629–3632
   PubMed Web of Science ®Google Scholar
• Kilbourn R. G., Griffith O. W. Overproduction of nitric oxide in cytokine activated septic shock. J. Natl. Cancer Inst. 1992; 84: 827–831
   PubMed Web of Science ®Google Scholar
• Kuijpers T. W., Raleigh M., Kavanagh T., Janssen H., Calafat J., Roos D., Harlan J. M. Cytokine-activated endothelial cells internalise E-selectin into a lysosomal compartment of vesiculotubular shape. J. Immunol. 1994; 152: 5060–5069
   PubMed Web of Science ®Google Scholar
• Levitzki A. Tyrphostins: Tyrosine kinase blockers as novel anti-proliferative agents and dissectors of signal transduction. FASEB J. 1992; 6: 3275–3282
   PubMed Web of Science ®Google Scholar
• McGregor P. E., Agrawal D. K., Edwards J. D. Attenuation of human leukocyte adherence to endothelial cell monolayers by tyrosine kinase inhibitors. Biochem. Biophys. Res. Commun. 1984; 198: 359–365
   Web of Science ®Google Scholar
• Moore K. L., Andreoli S. P., Esmon N. L., Esmon C. T., Bang N. U. Endotoxin enhances tissue factor and suppresses thrombomodulin expression on human vascular endothelium in vitro. J. Clin. Invest. 1987; 79: 124–130
   PubMed Web of Science ®Google Scholar
• Munoz E., Zubiaga A., Huang C K., Huber R. T. Interleukin-1 induces protein tyrosine phosphorylation in T-cells. Eur J. Immunol. 1992; 22: 1391–1396
   PubMed Web of Science ®Google Scholar
• Nakashima S., Koike T., Nozawa Y. Genistein, a protein tyrosine kinase inhibitor, inhibits thromboxane A2 mediated human platelet aggregation. Mol. Pharmacol. 1991; 39: 475–480
   PubMed Web of Science ®Google Scholar
• Novogrodsky A., Vanichkin A., Patya M., Gazit A., Osherov N., Levitski A. Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science 1994; 264: 1319–1322
   PubMed Web of Science ®Google Scholar
• Okusawa S., Gelfand J. A., Ikejima T., Connolly R. J., Dinarello C. A. Interleukin-1 induces a shock like state in rabbits. Synergism with tumour necrosis factor and the effect of cycloxygenase inhibition. J. Clin Invest. 1988; 81: 1162–1172
   PubMed Web of Science ®Google Scholar
• Oppenheimer-Marks N., Davis L. S., Lipsky P. E. Human T-lymphocyte adhesion to endothelial and transendothelial cell migration. Alteration of receptor use relates to the activation status of both the T-ceU and the endothelial cell. J. Immunol. 1990; 145: 140–148
   PubMed Web of Science ®Google Scholar
• Pfeffer K., Matsuyama T., Kundig T. M., Wakeham A., Kishihara K., Shahinian A., Wlegmann K., Ohashi P. S., Kronke M., Mak T. W. Mice deficient for the 55 Kd tumor necrosis factor receptor are resistant to endotoxic shock yet succumb to L. monocytogenes infection. Cell. 1993; 73: 457–467
   PubMed Web of Science ®Google Scholar
• Pugin J., Schurer-Maly C. C., Letureq D., Moriarty A., Ulevitch R. J., Tobias P. S. Lipopolsaccharide (LPS). Activation of human endothelial and epithelial cells is mediated by LPS-binding protein and soluble CD14. Proc. Natl. Acad. Sci. USA 1993; 90: 2744–2748
   PubMed Web of Science ®Google Scholar
• Read M. A., Cordle S. R., Veach R. A., Carlisle C. D., Hawiger J. Cell free pool of CD14 mediates activation of transcription factor NFkB by lipopolysaccharide in human endothelial cells. Proc. Natl. Acad. Sci. USA 1993; 90: 9887–9891
   PubMed Web of Science ®Google Scholar
• Rothe J., Lesslauer W., Lotscher H., Lang Y., Koebel P., Kontgen F., Althage A., Zinkernaggel R., Steinmetz M., Bluethmann H. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNFα mediated toxicity but are highly susceptible to infection by listeria monocytogenes. Nature 1993; 364: 798–802
   PubMed Web of Science ®Google Scholar
• Rothstein J. L., Schreiber H. Synergy between rumour necrosis factor and bacterial products causes haemorrhagic necrosis and lethal shock in normal mice. Proc. Natl. Acad. Sci. USA 1988; 85: 607–611
   PubMed Web of Science ®Google Scholar
• Schumann R. R., Leong S. R., Flaggs G. W., Gray P. W., Wright S. D., Mathison J. C., Tobias P. S., Ulevitch R. J. Structure and function of lipopolysaccharide binding protein. Science 1990; 249: 1429–1433
   PubMed Web of Science ®Google Scholar
• Shiraishi T., Owada M. K., Tatsuka M., Yamashita T., Wantanabe K., Kakunaga T. Specific inhibition of tyrosine specific protein kinases: properties of 4-hydroxy cinnamamide derivatives in vitro. Cancer Res. 1989; 49: 2374–2378
   PubMed Web of Science ®Google Scholar
• Shiraishi T., Owada M. K., Tatsuka M., Fuse Y., Wantanabe K., Kakunaga T. A tyrosine specific protein kinase inhibitor α-cyano-3-ethoxy-4-hydroxy-5-phenylthiomethyl-cinnamamide blocks the phosphorylation of tyrosine kinase substrates in intact cells. Jpn. J. Cancer Res. 1990; 81: 645–652
   PubMedGoogle Scholar
• Stefanova I., Corcoran M. L., Horak E. M., Wahl L. M., Bolen J. B., Horak I. D. Lipopolysaccharide induces activation of CD14 associated protein tyrosine kinase p53/p561yn. J. Biol. Chem. 1993; 268: 20725–20728
   PubMed Web of Science ®Google Scholar
• Tobias P. S., Mathison J., Mintz D., Lee J. D., Kravchenko V., Kato K., Pujin J., Ulevitch R. J. Participation of Epopolysaccharide binding protein in lipopolysaccharide dependent macrophage activation. Am. J. Resp. Cell. Mol. Biol. 1992; 7: 239–245
   PubMed Web of Science ®Google Scholar
• Uings I. J., Thompson N. T., Randall R. W., Spacey G. D., Bosner R. W., Hudson A. T., Garland L. G. Tyrosine phosphorylation is involved in receptor coupling to phospho-lipase D but not phospholipase C in the human neutrophil. Biochem. J. 1992; 281: 597–600
   PubMed Web of Science ®Google Scholar
• Ulevitch R. J., Tobias P. S. Recognition of endotoxin by cells leading to transmembrane signalling. Curr. Opinion. in Immunol. 1994; 6: 125–130
   PubMed Web of Science ®Google Scholar
• Vietor I., Schwenger P., Li W., Schlessinger J., Vilcek J. Tumour necrosis factor induced activation and increased tyrosine phosphorylation of mitogen activated protein (MAP) kinase in human fibroblasts. J. Biol. Chem. 1993; 268: 18994–18999
   PubMed Web of Science ®Google Scholar
• Weber C., Negrescu E., Erl W., Pietsch A., Frankenberger M., Loms, Ziegler-Heitbrock H. W., Siess W., Weber P. C. Inhibitors of protein tyrosine kinase suppress TNFα-stimulated induction of endothelial cell adhesion molecules. J. Immunol. 1995; 155: 445–451
   PubMed Web of Science ®Google Scholar
• Weinstein S. K., Gold M. R., DeFranco A. L. Bacterial lipopolysaccharide stimulates tyrosine phosphorylation in macrophages. Proc. Natl. Acad. Sci USA 1991; 88: 4148–4152
   PubMed Web of Science ®Google Scholar
• Wright S. D., Ramos R. A., Tobias P. S., Ulevitch R. J., Mathison J. C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS-binding proteins. Science 1990; 249: 143–1433
   Web of Science ®Google Scholar
• Yaish P., Gazit A., Gilon C., Levitzki A. Blocking of EGF dependent cell proliferation by EGF-receptor kinase inhibition. Science 1988; 242: 933–935
   PubMed Web of Science ®Google Scholar